Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
February 12, 2018 Off

New technique for downstream bioconjugation process from ADC Biotechnology

By Dino Mustafić

ADC Biotechnology is making a new method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and…

Xeris Pharmaceuticals gets new ODD from the USFDA
February 9, 2018 Off

Xeris Pharmaceuticals gets new ODD from the USFDA

By Dino Mustafić

Xeris Pharmaceuticals got its third orphane drug designation from the USFDA, this time for its treatment of Hyperinsulinemic Hypoglycemia.

BioPorto nets deal with Roche for distribution of test on Roche’s cobas analysers
February 9, 2018 Off

BioPorto nets deal with Roche for distribution of test on Roche’s cobas analysers

By Dino Mustafić

BioPorto and Roche agreed that BioPorto will deliver a neutrophil gelatinase-associated lipocalin (NGAL) test for use on Roche’s cobas c…

February 9, 2018 Off

Aquinox Pharmaceuticals enrolls the patients for testing ist lead drug candidate for bladder pain syndrome, results in Q3

By Dino Mustafić

Aquinox Pharmaceuticals has completed the list of candidates to be included in the clinical trial of its bladder pain syndrome…

February 9, 2018 Off

Immutep’s efti combination with Keytruda is safe, DSMB says

By Dino Mustafić

Immutep Limited’s combination of eftilagimod alpha with pembrolizumab (KEYTRUDA) is safe and well tolerated at doses up to 30 mg…

ViiV Healthcare sues Gilead over HIV drug containing bictegravir patent infringmenet, Gilead increases dividend 10% after posting net loss in Q4 2017
February 8, 2018 Off

ViiV Healthcare sues Gilead over HIV drug containing bictegravir patent infringmenet, Gilead increases dividend 10% after posting net loss in Q4 2017

By Dino Mustafić

ViiV Healthcare on Thursday said it has filed patent infringement litigation against Gilead Sciences Inc. over bictegravir in the United…

Novartis to update plaque psoriasis inhibitor Cosentyx
February 8, 2018 Off

Novartis to update plaque psoriasis inhibitor Cosentyx

By Dino Mustafić

Novartis got an approval from the USFDA for a label update for its plaque psoriasis inhibitor Cosentyx (secukinumab).

Circassia reaches new customers in USA through Vizient
February 8, 2018 Off

Circassia reaches new customers in USA through Vizient

By Dino Mustafić

Circassia Pharmaceuticals has received a multi-year Innovative Technology contract for its Niox Vero asthma management products from Vizient.

Pharmapack Europe Award Winners 2018
February 8, 2018 Off

Pharmapack Europe Award Winners 2018

By Dino Mustafić

Pharmapack Europe announced the winners of the much celebrated 2018 Pharmapack Awards. Due to the outstanding quality of entries, six worthy…

Sobi nets deal with Republic of Ireland to provide its therapies for haemophilia
February 7, 2018 Off

Sobi nets deal with Republic of Ireland to provide its therapies for haemophilia

By Dino Mustafić

Republic of Ireland’s Health Service Executive (HSE) and Sobi have signed a supply deal to offer people with with haemophilia haemophilia…

Posts pagination

Previous 1 … 3,406 3,407 3,408 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine